4/A

FORM 4/A SUBMISSION

Company: Alaunos Therapeutics, Inc.
Filed: January 6, 2014
Period of Report: December 31, 2013
Accession Number: 0001209191-14-002057

View Document ↗ View on SEC.gov ↗